The critique discusses 58 peptides in several clinical phases, indicating a robust pipeline of peptide therapies concentrating on PPIs. These tactics open new avenues for treatment options customized to overcome precise breast cancer subtypes and glioblastoma by honing in on integrins, fibronectins, and matrix metalloproteinases. That will help support the https://arthurs134iif4.wikigiogio.com/user